Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Bibliographic Details
Title:	Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Authors:	Harrison, Claire, Nangalia, Jyoti, Boucher, Rebecca H. ^, Jackson, Aimee ^, Yap, Christina ^, O'Sullivan, Jennifer ^, Fox, Sonia ^, Ailts, Isaak ^, Dueck, Amylou C, Geyer, Holly L. ^, Mesa, Ruben, Dunn, William ^, Nadezhdin, Eugene ^, Curto-Garcia, Natalia ^, Green, Anna ^, Wilkins, Bridget ^, Coppell, Jason ^, Laurie, John ^, Garg, Mamta ^, Ewing, Joanne ^, Knapper, Steve, Crowe, Josephine ^, Koutsavlis, Ioannis ^, Godfrey, Anna L ^, Arami, Siamak ^, Drummond, Mark W. ^, Byrne, Jennifer ^, Clark, Fiona J ^, Mead-Harvey, Carolyn ^, Baxter, Joanna E ^*, McMullin, Mary Frances, Mead, Adam J
Source:	In Blood 15 November 2022 140 Supplement 1:1781-1783
Database:	ScienceDirect